News

Our Healthcare News

Cardiva Medical Announces $45 Million Financing Led by EW Healthcare Partners

Robert S. White Joins Board of Directors

SANTA CLARA, California (GLOBE NEWSWIRE)—Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the…  

Jul 14 2020

MiMedx Announces Concurrent $150 Million Private Equity and Debt Financings

Equity Financing Led by EW Healthcare Partners and Debt Financing Provided by Hayfin Capital Management. EW Healthcare Partners Managing Director and Co-Founder Martin Sutter and…  

Jul 02 2020

Cobra Biologics signs supply agreement with AstraZeneca for manufacture of COVID-19 vaccine candidate

Providing large scale manufacturing capacity for AZD1222

Keele, UK, 16 June 2020: Cobra Biologics (Cobra), part of the Cognate BioServices family, an international CDMO for…  

Jun 16 2020

Xenex LightStrike Robot Destroys SARS-CoV-2 (Coronavirus) in 2 Minutes; First & Only UV Disinfection Technology Proven to Deactivate COVID-19 Virus

San Antonio – April 30, 2020 — SARS-CoV-2 is a global threat for which the world was unprepared. Xenex Disinfection Services announced today that its…  

Apr 30 2020

EyePoint Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Watertown, MASSACHUSETTS—(GLOBE NEWSWIRE)—EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products today announced the pricing of an underwritten…  

Feb 21 2020

Cognate BioServices closes Series B and completes acquisition of Cobra Biologics

MEMPHIS, Tennessee—Cognate BioServices, a leading contract development and manufacturing organization (CDMO) specialized in cell and cell-mediated gene therapy products today announced that it has completed…  

Jan 21 2020

Sonendo® Announces Growth Investment from EW Healthcare Partners

 
Leading Dental Technology Company Raises $85 Million to Accelerate Growth

LAGUNA HILLS, California—Sonendo, Inc., a leading dental technology company, announced today that…  

Jan 06 2020

TELA Bio Announces Closing of Initial Public Offering of Common Stock

MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement…  

Dec 13 2019

TELA Bio Awarded Contract with HealthTrust Purchasing Group

MALVERN, Pennsylvania—TELA Bio, Inc. (“TELA”) (Nasdaq: TELA), a commercial stage medical technology company focused on designing, developing and marketing a new category of tissue reinforcement…  

Dec 06 2019



View Legacy Fund news >